Jerel Davis's Form 4 filing
Chinook Therapeutics, Inc. (KDNY) · filed Aug 31, 2021
- Accession no.
- 0000899243-21-034628
- Filed
- Aug 31, 2021
- Trade date
- Aug 27, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $11.9M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jerel DavisCIK 0001745958 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2021 | Common Stock | SSaleDisposed | −510,000 | $14.00 | −$7,140,000 | 4,223,023 | Indirect | |
| Aug 27, 2021 | Common Stock | SSaleDisposed | −261,902 | $14.00 | −$3,666,628 | 2,171,197 | Indirect | |
| Aug 27, 2021 | Common Stock | SSaleDisposed | −78,098 | $14.00 | −$1,093,372 | 644,149 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.